Clinical Evaluation of Practolol, a New Cardioselective Beta-Blocking Agent in Angina Pectoris

BMJ
doi 10.1136/bmj.2.5706.399
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Clinical Evaluation of Propatylnitrate in Angina Pectoris

BMJ
1961English

Mechanism of Action of Adrenergic Receptor Blocking Agents in Angina Pectoris: Comparison of Action of Propranolol With Dexpropranolol and Practolol

BMJ
1969English

Comparison of Effects of Propranolol and Practolol on Exercise Tolerance in Angina Pectoris.

Heart
Cardiovascular MedicineCardiology
1971English

A Clinical Trial of Isocarboxazid (`Marplan') in Angina Pectoris

Heart
Cardiovascular MedicineCardiology
1962English

Experimental and Clinical Evaluation in Man of Hexamethonium (C6), a New Ganglionic Blocking Agent

Circulation
Cardiovascular MedicinePhysiologyCardiology
1950English

A Clinical Lecture ON THE CAUSATION OF ANGINA PECTORIS

BMJ
1910English

Angina Pectoris.

BMJ
1971English

Angina Pectoris

Postgraduate Medical Journal
Medicine
1929English

Hemodynamic Effects of Tilisolol, a New .BETA.-adrenergic Blocking Agent With Vasodilating Property, and Doxazosin, a New .ALPHA.-adrenergic Blocking Agent, in Essential Hypertension.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy